Neurocrine Biosciences, Inc. (BVMF:N1BI34)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 14, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	70,966	85,477	62,816	60,702	45,018	46,506
Market Cap Growth	-17.96%	36.07%	3.48%	34.84%	-3.20%	16.88%
Enterprise Value	67,552	79,652	58,830	57,973	43,273	44,289
Last Close Price	36.33	42.53	32.30	31.58	23.62	25.17
PE Ratio	31.11	40.49	51.85	74.32	90.18	21.99
PS Ratio	4.96	5.87	6.86	7.71	7.13	8.56
PB Ratio	4.43	5.34	5.80	6.72	5.88	7.95
P/TBV Ratio	4.49	5.43	5.91	6.90	5.88	7.95
P/FCF Ratio	22.45	24.80	35.80	35.56	34.66	41.15
P/OCF Ratio	20.91	23.21	33.20	33.83	31.50	39.19
EV/Sales Ratio	4.68	5.47	6.43	7.37	6.85	8.15
EV/EBITDA Ratio	19.90	21.11	29.14	41.44	35.51	25.37
EV/EBIT Ratio	23.26	22.09	30.71	44.04	37.38	26.04
EV/FCF Ratio	21.37	23.11	33.53	33.96	33.32	39.19
Debt / Equity Ratio	0.16	0.19	0.19	0.15	0.32	0.37
Debt / EBITDA Ratio	0.76	0.76	0.99	0.94	1.88	1.19
Debt / FCF Ratio	0.81	0.89	1.19	0.81	1.89	1.90
Asset Turnover	0.69	0.68	0.67	0.67	0.60	0.69
Inventory Turnover	17.15	15.99	16.48	14.85	11.71	12.59
Quick Ratio	2.89	3.06	2.25	2.49	3.65	5.14
Current Ratio	3.38	3.40	2.45	2.70	3.96	5.45
Return on Equity (ROE)	14.96%	14.16%	12.68%	10.03%	7.17%	46.20%
Return on Assets (ROA)	8.66%	10.46%	8.78%	7.01%	6.82%	13.46%
Return on Capital (ROIC)	10.41%	12.68%	10.66%	8.22%	7.75%	15.33%
Return on Capital Employed (ROCE)	14.90%	18.20%	15.20%	13.60%	11.40%	21.20%
Earnings Yield	3.21%	2.47%	1.93%	1.35%	1.11%	4.55%
FCF Yield	4.45%	4.03%	2.79%	2.81%	2.89%	2.43%
Buyback Yield / Dilution	1.30%	-2.67%	-2.12%	-1.02%	-0.10%	-2.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.